 |
 |
 |
U.S. Earmarks $1
Billion for Swine Flu Vaccine Development
According to numbers recently released by the
World Health Organization (WHO), the new H1N1 flu
has reached 42 countries, with 11,168 cases
confirmed by laboratory tests, and 86 deaths. The
CDC reported there have been 6,552 confirmed and
probable cases in 48 states and Washington, D.C.,
with nine deaths. The disease’s future course and
severity remain uncertain. After much pressure from
health officials all over the world, the WHO decided
to alter its criteria for declaring a pandemic,
taking into account both the severity and
geographical spread of the disease. While the flu
has been relatively mild so far, the current
pandemic alert stands at level 5, one notch shy of a
pandemic.
As the disease continues to spread, the U.S.
government has set aside $1 billion to launch
development of an H1N1 swine flu vaccine. The source
of the money is an existing federal fund for
pandemic flu and preparedness. It will be used for
both clinical studies conducted this summer and for
the production of two bulk ingredients that will be
placed in a federal stockpile. Should officials
decide to proceed with a large-scale vaccination
program, the bulk ingredients developed will be
used. While this newest move marks progress towards
vaccine development, it doesn’t mean that the
government has plans to definitely mass produce
shots. Instead, the actions will help prepare for
vaccinations if needed. This move also helps
alleviate the risk involved for the production of
ingredients for a vaccine that may or may not end up
being used. The Department of Health and Human
Services is placing orders for ingredients with
those manufacturers it already has under contract.
These same manufacturers were originally focused on
production of the H5N1 or avian flu vaccine.
Of the funds set aside for vaccine ingredient
production, Novartis AG will receive $289 million,
Sanofi Aventis SA will receive $191 million, and
GlaxoSmithKline PLC will be given $181 million.
Another $150 million will be directed to additional
manufacturers and others for production of pilot
lots of vaccine. It will also pay for clinical
studies to determine the vaccine’s safety, proper
dosage and whether adjuvants are necessary.
Adjuvants are ingredients that improve the immune
system’s response, reducing the amount of active
ingredient needed for the vaccine.
Two candidate viruses that could be used to make a
vaccine are currently being analyzed by scientists
at the CDC. The plan is to send one or both to
manufacturers so that production of pilot lots may
begin.
|
 |
 |
 |
 |
|
|
|
 |
|
|
 |
 |
 |
Chemical Information
Services
Releases Latest Version of DWCP on CD-Rom
Chemical
Information Services'' latest
version of the Directory of World Chemical
Producers (DWCP) CD-Rom is now available.
When it comes to finding worldwide producers
of chemical raw materials, there's no better
resource. This invaluable search tool
enables users to search by chemical name,
country, CAS number, functional group and
manufacturer.
The CD-Rom version puts four decades of
research and information at the user’s
fingertips. It provides essential data for
more than 214,000 product titles, including
112,000 synonyms, along with full contact
details for over 15,000 producers in 101
countries. With the addition of the
SearcHelper feature, the search
process is further streamlined, with scroll
down menus for searching by chemical name,
company and CAS number.

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
Compass Minerals
Names New Board Member
Paul S. Williams was named to the board of
directors of Compass Minerals earlier this
month. He will serve on the company's audit
and compensation committees. Mr. Williams
possesses 20 years of broad legal and
business experience counseling diverse
service and manufacturing businesses. He is
currently a partner in the firm of Major,
Lindsey & Africa. In addition, Mr. Williams
has been a member of the board of directors
of State Auto Financial Corporation since
2003 and of Bob Evans Farms since 2007.

Terra
Nitrogen Company, L.P. Makes Changes to Its
Board

Leading manufacturer of nitrogen
fertilizer products Terra Nitrogen Company,
L.P. recently announced changes to its board
of directors. Anne H. Lloyd has been elected
and will chair TNCLP’s Audit Committee. Ms.
Lloyd has held senior financial and
accounting positions within the industry.
Since 1998, she has been with Martin
Marietta Materials, Inc. and has served as
its Senior Vice President and Chief
Financial Officer since 2005 and was elected
Treasurer in 2006

LyondellBasell Appoints Group CEO
James Gallogly has been
appointed group CEO of Netherlands-based
petrochemicals producer LyondellBasell
Industries. He succeeded Volker Trautz who
recently announced his retirement.
Mr.Gallogly comes to the company from
ConocoPhilips, where he served as vice
president of exploration and production. The
terms of Gallogly’s appointment were subject
U.S. bankruptcy court’s approval.

Sigma-Aldrich Chairman
Retires
David Harvey
has retired as chairman of Sigma-Aldrich
Corporation. Mr. Harvey has held the
position since 2001 and joined the company
in 1974. He has served as chief operating
officer, president and chief executive. He
began his career with the company as senior
executive in charge of European operations,
served as president of Aldrich Chemical in
Milwaukee and executive vice president and
chief operating officer of Sigma-Aldrich.
Current president and CEO, Dr. Jai
Nagarkatti, has been elected by the
company’s directors to serve as chairman.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
DuPont Plans
Additional Job Cuts
U.S. chemical giant
DuPont reported that it plans to eliminate
an additional 2,000 jobs. These latest
reductions bring the company’s total to 7.5
percent. With these job cuts and related
plant closings, DuPont will save more than
$70 million this year and $225 million per
year by the end of 2010.
Last quarter, DuPont’s sales volumes
declined 19 percent, with decreases in every
segment except agriculture. As demand
continues to decline in automobile,
construction and industrial markets, the
company takes additional cost saving
measures in the U.S. One involves taking a
pretax charge of $340 million to $390
million in the second quarter, with 60
percent cash. DuPont will be eliminating
additional jobs in all of its regions, in
all units with the exception of agriculture.
In the second quarter, charges amounted to
approximately $225 million for severance and
related benefits, asset write-offs of $145
million and $35 mission for factory
dismantling and accelerated depreciation.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
|
|
 |
 |
|
Clariant Aims at
Personal Care Markets
Specialty
chemicals expert Clariant launched a concept
strategy to address the particular needs of
fast-growing personal care market segments.
The company’s concepts for men’s care and
wet wipes apply its expertise as well as its
broad portfolio of innovative skin care and
hair care lines, and extensive manufacturing
and R&D support.
Clariant’s men’s care concept focuses on the
broadening cosmetics product range for men
with product lines for cleansing, shaving
for sensitive skin, hair care, and skin,
face and sun care. It provides for customer
ease of choice and product development
efficiency through clear identification of
the specific ingredients and formulation
from the company’s broad personal care
product portfolio that are suited to men‘s
care applications.
Clariant’s wet wipe concept is driven by the
anticipated general increase in other wipe
applications such as facial cleansing,
make-up removal, personal hygiene, etc. The
goal is to ensure the end-manufacture of
convenient cosmetics without compromise and
it focuses its complete portfolio of
ingredients to bring maximum quality and
convenience to manufacturers and consumers.
The company’s Personal Care division is a
leading supplier to the Personal Care
industry with a global network of production
and R&D sites. Clariant’s product ranges
include emulsifiers, rheology modifiers,
conditioning agents, additives, actives
ingredients and cosmetic preservatives all
of which provide performance enhancement to
formulations using the latest technology and
natural ingredients.
|
|
 |
 |
|
|
|
|
|
 |
 |
URALCHEM Announces First Quarter Results
Russian nitrogen and
phosphate fertilizer producer, URALCHEM
recently reported its production results for
the first quarter of 2009. During the first
three months of the year, the company
produced 1.135m tonnes of commercial
products, an amount down 9% from the same
period of 2008. When compared to the fourth
quarter of 2008, the first quarter 2009
results demonstrate positive dynamics.
Despite the current global economic
situation, the company’s production
facilities were operating at full capacity.
While ammonia production was down 44%, urea
output was 44% higher. Ammonium nitrite
production increased 6% during the period.
Total production of nitrogen fertilizers,
which form the company’s key product line,
was 12% higher in January-March 2009.
Phosphate fertilizers production was down
compared with the same period of 2008.
Diammonium phosphate (DAP) production was
also down from first quarter of 2008
production. The company did not produce
monoammonium phosphate (MAP) in the
January-March 2009 period. It reported that
the decrease in phosphate fertilizer
production was due to difficulties in
purchasing phosphate rock, the key raw
material.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
| |
|
Aditya Birla
Nuvo Limited Restarts Fertilizer Complex
Following a shut down earlier this month,
India’s Aditya Birla Nuvo Limited (ABNL) has
resumed production at its ammonia-urea
complex. It was shut down due to an
equipment breakdown. The site, located at
the Uttar Pradesh State of Jagdishpur, is
comprised of a 501,600 tonnes/year ammonia
plant and an 864,000 tonnes/year urea plant.
The ammonia output produced is used
primarily for the company’s in-house urea
production.
This was the third time in three years that
technical issues have forced ABNL to shut
down. The collapse of a urea cooling tower
caused the company to shut down in 2007
while a fire temporarily forced them to do
so in June of 2008.
In results released last month, ABNL
reported that its fertilizer division has
more than doubled its operating profits to
$16.4m (814 Rs) in the fourth quarter
(January-March 2009).
|
|
 |
 |
 |
 |
 |
 |
 |
| |
|
 |
|
 |
|
|
|
|
|
 |
|
|
 |
|
|
|
|
|
 |
|
|
|
|